TheProfitWatch

IMTX - Immatics N.V. Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
10.2 0.64 (6.27%) --- --- --- -0.03 (-0.29%) 0.65 (6.38%) --- -0.03 (-0.29%)

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Category: /stock/categories/na
Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
70.0
VWAP:
10.83
RVol:

Events

Period Kind Movement Occurred At

Related News